Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment

Paul Derose, Philip E. Thorpe, David E. Gerber

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences